STRATA Skin Sciences (NASDAQ:SSKN) & GBS (NYSE:GBS) Financial Contrast

GBS (NYSE:GBS) and STRATA Skin Sciences (NASDAQ:SSKN) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, earnings, risk, valuation, institutional ownership and profitability.

Risk & Volatility

GBS has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500. Comparatively, STRATA Skin Sciences has a beta of 1.47, meaning that its share price is 47% more volatile than the S&P 500.

Earnings and Valuation

This table compares GBS and STRATA Skin Sciences’ revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GBS	$440,000.00	63.28	-$8.31 million	($0.56)	-3.34
STRATA Skin Sciences	$33.36 million	0.33	-$10.83 million	($3.30)	-0.94

GBS has higher earnings, but lower revenue than STRATA Skin Sciences. GBS is trading at a lower price-to-earnings ratio than STRATA Skin Sciences, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares GBS and STRATA Skin Sciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
GBS	N/A	-85.64%	-54.42%
STRATA Skin Sciences	-34.92%	-65.76%	-19.69%

Insider & Institutional Ownership

2.8% of GBS shares are owned by institutional investors. Comparatively, 32.4% of STRATA Skin Sciences shares are owned by institutional investors. 0.3% of GBS shares are owned by insiders. Comparatively, 40.4% of STRATA Skin Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for GBS and STRATA Skin Sciences, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GBS	0	0	0	0	N/A
STRATA Skin Sciences	0	0	0	0	N/A

STRATA Skin Sciences has a consensus price target of $38.00, indicating a potential upside of 1,121.86%. Given STRATA Skin Sciences’ higher probable upside, analysts clearly believe STRATA Skin Sciences is more favorable than GBS.

Summary

STRATA Skin Sciences beats GBS on 8 of the 12 factors compared between the two stocks.

About GBS

GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. GBS Inc. has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was incorporated in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

About STRATA Skin Sciences

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.